LJ Fairbairn

1.3k citations
32 papers · 1.0k indexed · h-index 17
  • Hematology top 5%
    • Acute Myeloid Leukemia Research 4
  • Immunology top 10%
    • Immune Cell Function and Interaction 4
  • Genetics top 10%
    • Virus-based gene therapy research 7
  • Oncology top 10%
    • Drug Transport and Resistance Mechanisms 3
    • DNA Repair Mechanisms 8
    • RNA Interference and Gene Delivery 8
    • Carcinogens and Genotoxicity Assessment 4
    • Lysosomal Storage Disorders Research 3

LJ Fairbairn

31 papers receiving 986 citations

Peers

LJ Fairbairn
Comparison fields: 5 of 87
  • Hematology 207
  • Immunology 257
  • Genetics 119
  • Oncology 295
  • Molecular Biology 566
Replace Mang Xiao with:
Mang Xiao China
Magdalena Plašilová United States
Nilamani Jena United States
Tetsuo Nishiura Japan
Bai-Wei Gu China
Frédéric Pendino France
Torsten Wüestefeld Germany
E Niskanen United States
E R Marsden United States
Manoj M. Pillai United States
LJ Fairbairn relative to Mang Xiao China Mang Xiao's profile →
Citations per field
00.5×1.5×
Mang Xiao · 1×
Citations per year

Countries citing papers authored by LJ Fairbairn

Since Specialization
Citations

This map shows the geographic impact of LJ Fairbairn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LJ Fairbairn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LJ Fairbairn more than expected).

Fields of papers citing papers by LJ Fairbairn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by LJ Fairbairn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LJ Fairbairn. The network helps show where LJ Fairbairn may publish in the future.

Co-authorship network

The 25 scholars most cited alongside LJ Fairbairn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with LJ Fairbairn Line = papers co-authored together LJ Fairbairn links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 200646
2 200520
3 20023
4 200121
5 20004
6 20004
7 199927
8 19992
9 19996
10 199942
11 199814
12 199827
13 199838
14 199719
15 199629
16 199639
17 19938
18 1993328
19 19934
20 198921

About LJ Fairbairn

LJ Fairbairn is a scholar working on Hematology, Cancer Research and Immunology, having authored 32 papers that have together received 1.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (8 papers), RNA Interference and Gene Delivery (8 papers), Virus-based gene therapy research (7 papers), Acute Myeloid Leukemia Research (4 papers), Carcinogens and Genotoxicity Assessment (4 papers), Immune Cell Function and Interaction (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Lysosomal Storage Disorders Research (3 papers). The work is most often cited by research in Hematology (207 citations), Immunology (257 citations) and Genetics (119 citations). LJ Fairbairn has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include T. M. Dexter, G.J. Cowling, Birgit M. Reipert, Joseph A. Rafferty, TM Dexter, David Buck, R. Heywood, B. I. Lord, Ian Hickson and L. H. Coutinho. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026